Skip to main content
Addgene

EF.STAT3C.Ubc.GFP
(Plasmid #24983)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 24983 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    cFUGW
  • Backbone size w/o insert (bp) 11500
  • Vector type
    Mammalian Expression, Lentiviral
  • Selectable markers
    EGFP

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    Stbl3
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    STAT3
  • Species
    H. sapiens (human)
  • Insert Size (bp)
    2314
  • Mutation
    A662C, N664C (constitutively active)
  • GenBank ID
    NM_139276.2
  • Entrez Gene
    STAT3 (a.k.a. ADMIO, ADMIO1, APRF, HIES)
  • Tag / Fusion Protein
    • FLAG (C terminal on insert)

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site PacI (destroyed during cloning)
  • 3′ cloning site PacI (destroyed during cloning)
  • 5′ sequencing primer EF1a-forward
  • 3′ sequencing primer hUBCpro-R
  • (Common Sequencing Primers)

Resource Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

A V667L mutation is present but not known to affect function.

Expression of EGFP is driven by the human ubiquitin promoter. See Addgene plasmid 14883: FUGW for more information on the empty vector.

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    EF.STAT3C.Ubc.GFP was a gift from Linzhao Cheng (Addgene plasmid # 24983 ; http://n2t.net/addgene:24983 ; RRID:Addgene_24983)
  • For your References section:

    The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?. Hillion J, Dhara S, Sumter TF, Mukherjee M, Di Cello F, Belton A, Turkson J, Jaganathan S, Cheng L, Ye Z, Jove R, Aplan P, Lin YW, Wertzler K, Reeves R, Elbahlouh O, Kowalski J, Bhattacharya R, Resar LM.. Cancer Research 68, 10121, December 2008. 10.1158/0008-5472.CAN-08-2121 PubMed 19074878